Australia markets close in 8 minutes

DIAGNOS Inc. (DGNOF)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
0.1983+0.0041 (+2.11%)
At close: 01:47PM EDT

DIAGNOS Inc.

7005 Taschereau Boulevard
Suite 265
Brossard, QC J4Z 1A7
Canada
450 678 8882
https://www.diagnos.ca

Sector(s)Healthcare
IndustryHealth Information Services
Full-time employees

Key executives

NameTitlePayExercisedYear born
Mr. Andre LarenteCEO, President & Executive Chairman212.2kN/AN/A
Mr. Marc-André MassueVP of Finance, CFO & Secretary102.92kN/AN/A
Mr. Yves-Stéphane CoutureChief Operating OfficerN/AN/AN/A
Mr. Martin BelandDirector of MarketingN/AN/AN/A
Amounts are as of 31 December 2023, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

DIAGNOS Inc. provides software-based services primarily in Canada, the United States, Colombia, Spain, Mexico, Saudi Arabia, and Costa Rica. The company offers healthcare services through Computer Assisted Retina Analysis, a web-based software tool that assists healthcare professionals for the detection of diabetic retinopathy; and allows eye care specialist to visualize both normal retinal landmarks and pathological changes. It also provides various consulting services in the fields of data analysis and artificial intelligence. DIAGNOS Inc. was founded in 1998 and is headquartered in Brossard, Canada.

Corporate governance

DIAGNOS Inc.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.